2001Unpublished venueRequires access

Expression and correlation between p16 oncoprotein and PCNA in astrocytic tumors with various malignancy

Chen Chen

Open publisher page 0 citations

Abstract

Objective To detect the expression of p16 oncoprotein and proliferating cell nuclear antigen (PCNA) in astrocytic tumors. Methods SP immunohistochemical analysis method was used. Results ①The expression of p16 oncoprotein in astrocytic tumors (LI mean=28.50%) was remarkably weaker than that in non- tumor brain tissues (LI mean=62.25%). The intensity of p16 staining was stronger in tumors with lower grade of malignancy; ②In astrocytic tumors, a significant negative correlation ( r=0.83, P 0.01) was observed between the p16 oncoprotein and PCNA labeling index (LI). Conclusion Immunohistochemical analysis of p16 oncoprotein combined with PCNA expression might be useful not only in deciding the grade of malignancy but also in some prognosis value in astrocytic tumors.

About this research paper

What this paper is about

Objective To detect the expression of p16 oncoprotein and proliferating cell nuclear antigen (PCNA) in astrocytic tumors. Methods SP immunohistochemical analysis method was used. Results ①The expression of p16 oncoprotein in astrocytic tumors (LI mean=28.50%) was remarkably weaker than that in non- tumor brain tissues (LI mean=62.25%). The intensity of p16 staining was stronger in tumors with lower grade of malignancy; ②In astrocytic tumors, a significant negative correlation ( r=0.83, P 0.01) was observed between the p16 oncoprotein and PCNA labeling index (LI). Conclusion Immunohistochemical analysis of p16 oncoprotein combined with PCNA expression might be useful not only in deciding the grade of malignancy but also in some prognosis value in astrocytic tumors.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To detect the expression of p16 oncoprotein and proliferating cell nuclear antigen (PCNA) in astrocytic tumors. Methods SP immunohistochemical analysis method was used. Results ①The expression of p16 oncoprotein in astrocytic tumors (LI mean=28.50%) was remarkably weaker than that in non- tumor brain tissues (LI mean=62.25%). The intensity of p16 staining was stronger in tumors with lower grade of malignancy; ②In astrocytic tumors, a significant negative correlation ( r=0.83, P 0.01) was observed between the p16 oncoprotein and PCNA labeling index (LI). Conclusion Immunohistochemical analysis of p16 oncoprotein combined with PCNA expression might be useful not only in deciding the grade of malignancy but also in some prognosis value in astrocytic tumors.

Key concepts: Proliferating cell nuclear antigen, Immunohistochemistry, Malignancy, Pathology, Biology, Staining, Cancer research, Correlation

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and correlation between p16 oncoprotein and PCNA in astrocytic tumors with various malignancy — Research Paper | ScholarLens